The people of the United Kingdom voted by 52% to 48% to leave the European Union (EU) in June 2016, a referendum decision intended by a slim majority to restore national self-determination and achieve what many believed to be a...
As a result of SeeAbility’s campaigning, NHS England are planning for a new national programme of sight tests and glasses dispensing in England’s special schools from 2020. SeeAbility’s model of sight testing is less stressful for children with learning disabilities...
David Shahnazaryan, Consultant Ophthalmologist, London, UK and Radhika Rampat, Consultant Ophthalmologist, London, UK, report from the AECOS Symposium in Antwerp, Belgium (June 10-12).
The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.
A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...
The Lord Provost of Edinburgh, Councillor Robert Aldridge, has praised Sight Scotland Veterans for the ‘incredible support’ it provides to veterans living with sight loss during a recent visit to the charity’s Linburn Centre in West Lothian. The Lord Provost,...